Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
Retinal nerve fibre layer and brain grey substance as early prognostic factors for disability in multiple sclerosis.
Metabolic Control of Th17 Cell Generation and CNS Inflammation.
Baló's Concentric Sclerosis in Multiple Sclerosis.
Relocation of p25¿/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
The therapeutic potential of cannabis and cannabinoids.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
Moyamoya disease can masquerade as multiple sclerosis.
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Season of birth as a risk factor for multiple sclerosis in Brazil.
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Pages
« first
‹ previous
…
221
222
223
224
225
226
227
228
229
…
next ›
last »